Human medicines European public assessment report (EPAR): Jinarc, tolvaptan, Polycystic Kidney, Autosomal Dominant, Date of authorisation: 27/05/2015, Revision: 20, Status: Authorised

Human medicines European public assessment report (EPAR): Jinarc, tolvaptan, Polycystic Kidney, Autosomal Dominant, Date of authorisation: 27/05/2015, Revision: 20, Status: Authorised